Royal Bank of Canada
KERX

Royal Bank of Canada’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Royal Bank of Canada’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-18,800
Closed -$243K – 6264
2013
Q4 		$243K Buy
+18,800
New +$225K ﹤0.01% 4018

Royal Bank of Canada's KERX Position: Q4 2018 in Review

Royal Bank of Canada sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 3,012 shares — an estimated $10K sold.

Royal Bank of Canada first reported a position in KERX in Q3 2013 and held it in 20 quarters. The position peaked at $444K in Q4 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Royal Bank of Canada reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Royal Bank of Canada sold 3,012 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $10K.
  • Royal Bank of Canada first reported a position in Keryx Biopharmaceuticals Inc in Q3 2013 and held it in 20 quarters.
  • Royal Bank of Canada's Keryx Biopharmaceuticals Inc position peaked at $444K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Royal Bank of Canada's 13F filing for Q4 2018, filed 14 Feb 2019.